145 related articles for article (PubMed ID: 28109948)
1. Design and synthesis of novel tetrandrine derivatives as potential anti-tumor agents against human hepatocellular carcinoma.
Lan J; Wang N; Huang L; Liu Y; Ma X; Lou H; Chen C; Feng Y; Pan W
Eur J Med Chem; 2017 Feb; 127():554-566. PubMed ID: 28109948
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel C
Lan J; Huang L; Lou H; Chen C; Liu T; Hu S; Yao Y; Song J; Luo J; Liu Y; Xia B; Xia L; Zeng X; Ben-David Y; Pan W
Eur J Med Chem; 2018 Jan; 143():1968-1980. PubMed ID: 29133049
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis of Novel Tetrandrine-14-l-Amino Acid and Tetrandrine-14-l-Amino Acid-Urea Derivatives as Potential Anti-Cancer Agents.
Hu SC; Yang J; Chen C; Song JR; Pan WD
Molecules; 2020 Apr; 25(7):. PubMed ID: 32283819
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of new tetrandrine derivatives and their antitumor activities.
Wei X; Qu TL; Yang YF; Xu JF; Li XW; Zhao ZB; Guo YW
J Asian Nat Prod Res; 2016 Oct; 18(10):966-75. PubMed ID: 27244089
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological activities of tetrandrine and fangchinoline derivatives as antitumer agents.
Li D; Liu H; Liu Y; Zhang Q; Liu C; Zhao S; Jiao B
Bioorg Med Chem Lett; 2017 Feb; 27(3):533-536. PubMed ID: 28057423
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines.
Ng LT; Chiang LC; Lin YT; Lin CC
Am J Chin Med; 2006; 34(1):125-35. PubMed ID: 16437745
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of tetrandrine derivatives.
Wu CZ; Lai L; Hu X; Lei RR; Yang YF
J Asian Nat Prod Res; 2013 Sep; 15(9):993-1002. PubMed ID: 23944846
[TBL] [Abstract][Full Text] [Related]
8. Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma.
Liu C; Gong K; Mao X; Li W
Int J Cancer; 2011 Sep; 129(6):1519-31. PubMed ID: 21128229
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 5-Alkynyltetrandrine Derivatives and Evaluation of their Anticancer Activity on A549 Cell Lines.
Niu N; Qu T; Xu J; Lu X; Bodwell GJ; Zhao Z
Anticancer Agents Med Chem; 2019; 19(12):1454-1462. PubMed ID: 30961510
[TBL] [Abstract][Full Text] [Related]
10. Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase.
Yu VW; Ho WS
Oncol Rep; 2013 Jun; 29(6):2205-10. PubMed ID: 23525490
[TBL] [Abstract][Full Text] [Related]
11. Tetrandrine-induced apoptosis is mediated by activation of caspases and PKC-delta in U937 cells.
Jang BC; Lim KJ; Paik JH; Cho JW; Baek WK; Suh MH; Park JB; Kwon TK; Park JW; Kim SP; Shin DH; Song DK; Bae JH; Mun KC; Suh SI
Biochem Pharmacol; 2004 May; 67(10):1819-29. PubMed ID: 15130759
[TBL] [Abstract][Full Text] [Related]
12. 9-bis[2-(pyrrolidin-1-yl)ethoxy]-6-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-11H-indeno[1, 2-c]quinolin-11-one (BPIQ), A Quinoline Derivative Inhibits Human Hepatocellular Carcinoma Cells by Inducing ER Stress and Apoptosis.
Chang WT; Fong Y; Chuang SC; Chou CK; Chou HL; Yang CF; Tseng CH; Chen YL; Chiu CC
Anticancer Agents Med Chem; 2017; 17(5):692-700. PubMed ID: 27491935
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives.
Gao XZ; Lv XT; Zhang RR; Luo Y; Wang MX; Chen JS; Zhang YK; Sun B; Sun JY; Liu YF; Liu C
Bioorg Chem; 2021 Apr; 109():104694. PubMed ID: 33601141
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents.
Chen JT; Ma R; Sun SC; Zhu XF; Xu XL; Mu Q
Bioorg Med Chem; 2018 Feb; 26(3):609-622. PubMed ID: 29310863
[TBL] [Abstract][Full Text] [Related]
15. Neferine isolated from Nelumbo nucifera enhances anti-cancer activities in Hep3B cells: molecular mechanisms of cell cycle arrest, ER stress induced apoptosis and anti-angiogenic response.
Yoon JS; Kim HM; Yadunandam AK; Kim NH; Jung HA; Choi JS; Kim CY; Kim GD
Phytomedicine; 2013 Aug; 20(11):1013-22. PubMed ID: 23746959
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, molecular modelling, and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma.
Ahmed NM; Youns M; Soltan MK; Said AM
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1110-1120. PubMed ID: 31117890
[TBL] [Abstract][Full Text] [Related]
17. Tetrandrine Enhances Radiosensitization in Human Hepatocellular Carcinoma Cell Lines.
Zhao XM; Hu WX; Wu ZF; Chen YX; Zeng ZC
Radiat Res; 2018 Oct; 190(4):385-395. PubMed ID: 29979637
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
[TBL] [Abstract][Full Text] [Related]
19. Galangin inhibits proliferation of hepatocellular carcinoma cells by inducing endoplasmic reticulum stress.
Su L; Chen X; Wu J; Lin B; Zhang H; Lan L; Luo H
Food Chem Toxicol; 2013 Dec; 62():810-6. PubMed ID: 24161691
[TBL] [Abstract][Full Text] [Related]
20. H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2.
Wei N; Liu GT; Chen XG; Liu Q; Wang FP; Sun H
Biochem Pharmacol; 2011 Dec; 82(11):1593-603. PubMed ID: 21864508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
